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Abstract
African swine fever virus (ASFV) enters cells by receptor mediated endocytosis and requires a fusion event between the
viral envelope and the limiting membrane of the endosome at low pH. In order to investigate the role of cholesterol in the
early stages of ASFV infection, we have studied the effect of the removal of cell and viral membrane cholesterol by
cholesterol oxidase treatment of cells and virions, as well as the effect of some inhibitors of cholesterol synthesis on the
infectious pathway. In addition, we have investigated viral infection in cholesterol-depleted Vero cells. Both cholesterol-
depleted and cholesterol oxidase-treated Vero cells were unaltered in their ability to bind or internalize the virus, but were
blocked in ASFV fusion and subsequent virus replication. Our results indicate that ASFV infection is affected by cholesterol
in the target membrane. ß 1998 Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
African swine fever virus (ASFV), the only repre-
sentative of an as yet unnamed family of DNA vi-
ruses, is a cytoplasmic virus with an icosahedral cap-
sid surrounded by two lipid envelopes [1]. ASFV is
responsible for an important and highly contagious
disease which attacks domestic pigs causing heavy
economic losses [2]. The available data show that
ASFV enters sensitive cells by a process of receptor
mediated endocytosis [3,4], and that the fusion of the
viral membrane with the membrane of an endosome
is triggered at the acidic pH generated in this organ-
elle, in order to deliver the viral DNA into the cyto-
plasm [5].
It has been previously shown, using sensitive and
simple £uorescence assays, that ASFV is able to fuse
with liposomes of various lipid compositions, and
that the fusion is more extensive with negatively
charged phospholipids, cardiolopin (CL) or phospha-
tidylserine (PS), and is reduced in the presence of the
zwitterionic phospholipid phosphatidylcholine (PC),
but not phosphatidylethanolamine (PE) [6]. How-
ever, the e¡ect of lipid composition on viral penetra-
tion and cell infection has not yet been studied. Cho-
lesterol is a major component of cell membranes,
exhibiting di¡erent e¡ects on membrane fusion, de-
pending on the experimental system studied. These
systems include the fusion of enveloped viruses with
target membranes, such as liposomes [7^9], and cul-
tured cells [9^11]. For example, modulation of viral
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membrane fusion by cholesterol appears to have dif-
ferent e¡ects depending on the system studied. For
example, fusion of Semliki Forest virus (SFV) [10,11]
and Sendai virus [12] required cholesterol in the tar-
get cell membrane or liposome, although in another
study cholesterol appeared to decrease Sendai virus
fusion [13]. On the other hand, supplementation of
cells with cholesterol (resulting in increased mem-
brane cholesterol/fatty acid ratio) led to a marked
enhancement of mouse hepatitis virus-mediated cell
fusion [14].
Some of the above studies were done employing
W-7, cerulenin and miconazole, which are known to
suppress cholesterol metabolism in a variety of cell
types [15], to investigate the e¡ects of cholesterol on
viral fusion and infectivity [16]. Another method con-
sisted of studying the importance of this sterol in the
fusogenic activity of viruses by measuring fusion
with erythrocyte membranes enriched or depleted
of cholesterol upon incubation with cholesterol-rich
liposomes or pure phospholipid liposomes [17]. Mu-
tant cells defective in cholesterol biosynthesis have
also been used to ascertain the role of cholesterol
in the fusion of Sendai virus [18]. The cholesterol
content of the virus membrane may also be a deter-
minant of the fusion activity of the virus. In certain
viruses such as SFV, the fusogenic activity is inde-
pendent of the presence of cholesterol in the ‘viro-
some’ membrane [19]. On the other hand, VSV and
Sendai virus need this sterol in their envelopes for
fusion activity [20,21].
The purpose of the present work was to investigate
the importance of cholesterol in cell infection by
ASFV (1) by altering the cell cholesterol metabolism,
(2) by altering the cholesterol levels either of the
virus or the cell membrane, and (3) using sterol-de-
pleted cells.
Our results show that all the above procedures
result in a signi¢cant inhibition of infectivity of
Vero cells by ASFV, suggesting a crucial role of cho-
lesterol in the early stages of this process.
2. Materials and methods
2.1. Cells and virus
Vero cells (obtained from ATCC, USA) were
grown as monolayers in Dulbecco’s modi¢ed Eagle’s
medium (DME) supplemented with 10% newborn
calf serum (NCS) and gentamicin (50 Wg/ml), both
purchased from Gibco (Scotland). The Lisbon 60
strain of ASFV was a gift from Dr. J. Viga¤rio [22].
Adaptation to grow in monkey cells was produced in
Vero cells, as described [23]. To produce labeled vi-
rus, 20 WCi/ml of [3H]thymidine (speci¢c activity 50^
60 Ci/mmol, Amersham, England) was added to the
medium following 2 h infection. The virus was har-
vested after 24 h incubation, and puri¢ed in Percoll
(Pharmacia, Sweden) gradients [23].
2.2. Inhibitors of cholesterol synthesis
The inhibitors used were cerulenin, W-7 and mico-
nazole (Sigma). Cerulenin was dissolved in methanol/
chloroform (5:1) and stored at 320‡C.
For studying the e¡ect of cholesterol synthesis in-
hibitors on ASFV infection, the virus (1^2 pfu/cell)
was adsorbed to cells for 2 h at 4‡C in the presence
of various concentrations of the inhibitors. Then the
medium was removed and the cells were incubated at
37‡C with new medium with the same concentrations
of the drugs. The yield of viruses was determined 24 h
post infection, when extensive c.p.e. was achieved in
the control infected cells without the inhibitors.
2.3. Virus binding
Brie£y, virus binding was measured as previously
described [24]. Vero cells were grown to con£uence
(106 cells/dish) in Petri dishes of 35 mm diameter
(P35) washed twice with cold PBS, and cooled (4‡C)
for 15 min. Labeled ASFV (3^5 pfu/cell) in 200 Wl of
ice-cold PBS was added to each Petri dish, and the
dishes were gently shaken for 2 h at 4‡C. Following
this incubation, the free virus was removed and the
cell monolayers were washed twice with cold PBS.
Cells were then scraped from the dishes, the dishes
were washed twice with cold PBS, and the cells were
pelleted by low speed centrifugation. Bound virus is
de¢ned as that virus which was cell-associated under
these conditions. After removal of the supernatant,
cells were lysed by addition of PBS containing 1%
SDS for 1 h at 0‡C. One hour after the addition of
an equal volume of cold 20% TCA, the precipitates
were collected on a Millipore ¢lter (GF/C), washed
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with 5% TCA and the radioactivity determined in a
Beckman LS-100 liquid scintillation spectrometer
[24].
2.4. Virus endocytosis
Measurements of virus uptake (endocytosis) were
performed after warming the samples of infected
cells, following virus binding, for various periods at
37‡C in DME. Following incubation of labeled virus
with cells, the medium was removed, the cells were
washed with cold PBS and incubated with proteinase
K in PBS (500 Wg/ml). After 1 h of shaking at 4‡C,
the cells were washed and scraped in PBS containing
0.2% bovine serum albumin (BSA) and 1 mM phe-
nylmethylsulfonyl £uoride (PMSF). Cell-associated
radioactivity (internalized virus) was determined as
described before for the binding experiments. Pro-
teinase K digestion allowed to separate surface-
bound from internalized viruses [24].
2.5. Virus fusion
For fusion studies, [3H]thymidine-labeled ASFV
was bound to cells as described above, cells were
incubated at 37‡C in medium at low pH (20 mM
succinate bu¡er, pH 5.5) to trigger virus-plasma
membrane fusion, non-fused virus removed by pro-
teinase K digestion, and cell-associated radioactivity
determined, as before [24].
2.6. Virus penetration (uncoating)
For penetration assays [3H]thymidine-labeled
ASFV was prebound to cells and internalized as de-
scribed before [24]. At given intervals the samples
were placed on ice to stop the process. The super-
natant was removed and total and soluble radioac-
tivity was assayed following protein precipitation
with 10% TCA at 0‡C. The cells were overlaid with
cold PBS containing 10 mM MgCl2 [25], removed
from the dishes by scraping, transferred to Eppen-
dorf tubes at 0‡C and pelleted for 30 s in a Beckman
microfuge at 4‡C. The supernatant was aspirated and
the same bu¡er added. The cells were passed 30 times
through a 24 gauge needle at 0‡C which resulted in
more than 99% lysis [26]. PBS containing 200 Wg/ml
of DNase (Sigma) was added to each sample and the
samples warmed to 37‡C for 30 min. Parallel experi-
ments were done without added nuclease to obtain
the background breakdown by cellular nucleases.
The samples were ¢nally cooled to 0‡C, precipitated
by adding an equal volume of 20% TCA at 0‡C,
incubated for 1 h and the soluble radioactivity deter-
mined as described above. All experiments were per-
formed at least twice.
2.7. Depletion of cellular cholesterol
Vero cells were partially depleted of cholesterol by
growing for 3 days in DME with 8% delipidated FCS
(Sigma). During the last 24 h of growth, 10 Wg/ml of
miconazole was added to this medium. Cholesterol
was assayed with the Boehringer Mannheim Diag-
nostics High Performance K-kit. The protein concen-
tration was determined by Lowry-Peterson assay
[27].
2.8. Cholesterol oxidase treatment of cells and virus
For maximal oxidation, Vero cells and puri¢ed
virus were pre¢xed with 2% glutaraldehyde for
15 min on ice, and treated for 1 h with cholesterol
oxidase (5.5 or 11 U/ml) in 310 mM sucrose and
0.5 mM Na3PO4, pH 7.4 [28]. For infectivity studies
the enzymatic treatment was performed without pre-
vious ¢xation.
2.9. Lipid analysis
For chromatographic analysis of the lipids, viral
lipids were extracted from enzyme-treated and un-
treated virus, which were lyophilized in a conical
centrifuge tube and the resulting dry powder was
immersed in 0.1 ml of chloroform/methanol (1:1).
After warming the mixture for a few minutes at
40‡C, all the chloroform/methanol extract was trans-
ferred as one spot on a silica gel G plate. Cellular
lipids from oxidase-treated cells or cholesterol de-
pleted cells were extracted as previously described
[29], and the lipid extracts were concentrated under
N2 atmosphere and spotted together with standards
on silica gel G plates. The plates were developed and
visualized by I2 vapor.
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3. Results
We explored several methods to assess the impor-
tance of cholesterol in the infectious pathway of
ASFV. First, we used several inhibitors of cholesterol
synthesis (W-7, cerulenin, and miconazole). The re-
sults in Table 1 indicate that all inhibitors studied at
non-cytotoxic concentrations (maximal non-cyto-
toxic concentrations were determined by Finter assay
[30]) decreased signi¢cantly the viral yield. Second,
Vero cells or puri¢ed ASFV were treated with cho-
lesterol oxidase, which speci¢cally oxidizes the 3L-
hydroxyl group of cholesterol to produce cholester-
one [28], and tested for binding, fusion ability and
infectivity. The results presented in Table 2 indicate
that the binding of puri¢ed ASFV to oxidase or
mock-treated cells in the cold was identical. Similar
results were also obtained for the binding and infec-
tivity of the treated virus. However, fusion at low pH
of the virus previously bound to oxidase-treated cells
was signi¢cantly inhibited (Fig. 1, Table 2). Under
these conditions, the oxidation of cellular cholesterol
was 54%. It is interesting to note that fusion at low
pH of cholesterol oxidase-treated virus with the plas-
Table 1










The drug was present all the time after infection (1^2 pfu/cell),
and the titers were determined by plaque assay at 24 h post in-
fection. Each value represents the average of three separate ex-
periments. All drugs were used at non-cytotoxic concentrations.
Table 2





Binding (% control) Fusion (% control) Infectivity (% control)
5.5 Vero cells 102 62 ND
ASFV ND 98 85
11 ASFV 99 ND 100
Vero cells in suspension were pretreated with cholesterol oxidase as described in Section 2. [3H]Thymidine-labeled ASFV (3^5 pfu/ml),
strain Lisbon 60 was bound at 4‡C for 2 h to enzyme- or mock-treated cells. Binding was expressed as the percentage of radioactivity
of control bound virus. The same virus preparation (3^5 pfu/ml) was treated or not with cholesterol oxidase, and binding was ex-
pressed as described above. For fusion assays, following treatment of virus or cells with cholesterol oxidase, fusion was induced by in-
cubation at acidic pH for 5 min at 37‡C. Non-fused virus was removed by digestion with proteinase K, and fusion expressed as the
percentage of radioactivity of control bound virus which became protease resistant. For infectivity experiments, following enzymatic
treatment of the virus, ASFV (1^2 pfu) was inoculated into the cells and the viral titers were calculated 24 h post infection, and ex-
pressed as the percentage of control viral titer. Each value represents the average of three separate experiments. ND, not done.
Fig. 1. E¡ect of cholesterol oxidase treatment of Vero cells on
ASFV fusion activity. Vero cells in suspension were pretreated
with cholesterol oxidase as described in Section 2.
[3H]Thymidine-labeled ASFV was bound at 4‡C to cholesterol
oxidase or mock-treated cells at pH 7.4, non-bound virus was
removed by washing, and the cells were incubated for 5 min at
either pH 7.4 or 5.5 at 37‡C to induce virus fusion with the
plasma membrane. Non-fused virus was removed by digestion
with proteinase K, and fusion was expressed as the percentage
of radioactivity of the initially bound virus which became pro-
tease resistant.
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ma membrane of non-treated cells was essentially
identical to that for non-treated virus (Table 2).
Vero cells can be depleted of cholesterol using de-
lipidated serum and miconazole in the culture me-
dium. After 72 h of culture under depleting condi-
tions, cholesterol levels were found to have declined
to 56% of those for control cells (data not shown).
We then followed the steps of viral entry into these
cells, and the results obtained for the binding (not
shown) and endocytic uptake of ASFV were compa-
rable for control and cholesterol-depleted cells,
showing that the cells were essentially healthy after
substantial depletion (Fig. 2A). However, viral pen-
etration was signi¢cantly decreased in cholesterol-de-
pleted cells, as illustrated by a lower rate of DNA
release (Fig. 2B). These results show that sterol de-
pletion decreased intracellular virus fusion, but that
the levels of sterol in the depleted cells were still
su⁄cient to allow some fusion. Curiously, low pH-
induced fusion at the plasma membrane in these cells
was essentially blocked (Fig. 3).
The images obtained by electron microscopy (re-
sults not shown) showed that following cholesterol
oxidase treatment, the viral and cellular membrane
integrity remains una¡ected. A comparison of the
two-dimensional thin-layer chromatograms for con-
trol and cholesterol oxidase-treated cells or cholester-
ol-depleted cells showed no di¡erence between the
phospholipid composition of the three cell prepara-
tions. However, the cholesterol spots were signi¢-
cantly decreased in both cholesterol-depleted or oxi-
dase-treated cells (data not shown).
Fig. 2. Kinetics of ASFV endocytosis and DNA penetration in
control and cholesterol-depleted Vero cells. (A) Endocytic up-
take. [3H]Thymidine-labeled ASFV was prebound for 120 min
at 4‡C to control (E) or cholesterol-depleted (F) Vero cells at
pH 7.4, and the non-bound virus was removed by washing. The
cells were warmed to 37‡C for the indicated period, extracellu-
lar viruses stripped o¡ by proteinase K digestion, and radioac-
tivity of internalized virus was counted. (B) Kinetics of viral
DNA delivery into the cytoplasm. [3H]Thymidine-labeled ASFV
was prebound and internalized as described in A. At the indi-
cated times, the cells were homogenized and the accessibility of
viral DNA to degradation by exogenous DNase was assayed.
Viral DNA penetration is expressed as the percentage of radio-
activity of endocytosed viral DNA that was degraded by
DNAse.
Fig. 3. E¡ect of cholesterol depletion of Vero cells on ASFV
fusion activity. Vero cells were depleted of cholesterol by grow-
ing in DME with 8% delipidated FCS and 10 Wg/ml of micona-
zole. [3H]Thymidine-labeled ASFV was bound at 4‡C to control
or cholesterol-depleted cells at pH 7.4 and non-bound virus re-
moved. The cells were then incubated for 5 min at 37‡C at ei-
ther pH 7.4 or 5.5 to induce virus fusion with the plasma mem-
brane. Non-fused virus was removed by digestion with
proteinase K, and fusion was expressed as the percentage of ra-
dioactivity of the initially bound virus which became protease
resistant.
BBALIP 55271 27-7-98
C. Bernardes et al. / Biochimica et Biophysica Acta 1393 (1998) 19^25 23
4. Discussion
Taken together, these results demonstrate that
cholesterol is required to allow ASFV fusion with
the endosome membrane of the host cell. Our studies
suggest that this sterol requirement for ASFV fusion
is an essential feature of the target plasma mem-
brane, rather than that of the virus membrane.
Thus, although puri¢ed virus particles contain cho-
lesterol in the virus membrane, they require choles-
terol in the target membrane in order to e⁄ciently
fuse. The inhibition of fusion and infection in cho-
lesterol oxidase-treated cells suggests that this sterol
3L-hydroxyl group is required for ASFV fusion with
a complex biological membrane.
The sterol depletion in Vero cells decreased intra-
cellular virus fusion and blocked the low pH-induced
fusion with the cell membrane more drastically than
in cholesterol oxidase-treated cells. This di¡erence
may be explained by the fact that arti¢cially induced
fusion at the plasma membrane requires more cho-
lesterol than intracellular fusion and/or that sterol
depletion is more pronounced in the plasma mem-
brane compared to that of the endosomal membrane.
The need of cellular cholesterol is also demonstrated
by the results obtained with cholesterol oxidase-
treated virus. Binding, low pH-induced fusion with
the plasma membrane, and infectivity of the treated
virus are not altered as compared to the control vi-
rus.
The cholesterol requirement in the entry pathway
of some enveloped viruses is well demonstrated for
alphaviruses [10,11]. These studies [11] have shown
that cholesterol is necessary and su⁄cient for low
pH-dependent binding of SFV to liposomes, while
sphingolipids are essential for induction of the actual
fusion event. However, other enveloped viruses that
use endocytosis and low pH to infect cells do not
have a similar sterol requirement. Both in£uenza vi-
rus, an orthomyxovirus, and VSV, a rhabdovirus,
have cholesterol-independent fusion mechanisms
[31,32]. Some non-enveloped viruses, such as polio-
virus, are known to enter cells via endocytosis and to
require a low pH membrane translocation step, but
cholesterol is not an essential component of the
membrane [33].
When the viruses do not need cholesterol in the
target membrane for infection, it seems that they
require this sterol in their membrane. In the case of
VSV, when the cholesterol content on its membrane
decreases, the infectivity of the virus is a¡ected ad-
versely [20]. Treatment of in£uenza virus with cho-
lesterol oxidase reduces the hemolytic activity of the
virus, but does not appear to alter its cell-cell fusion
activity [34]. It is known that the lack of cholesterol
can modify the conformational state of viral fusion
proteins and a¡ect the insertion of the hydrophobic
sequences of these proteins into the target membrane
[35].
ASFV does not appear to require cholesterol in its
membrane, but the presence of this lipid in the target
membrane is important for infection.
The crucial role of cholesterol in the ASFV infec-
tious entry into cells is also illustrated by the low
viral yield obtained in the presence of several com-
pounds which interfere with cholesterol metabolism.
It has been reported that W-7, cerulenin, and mico-
nazole inhibit the cell fusion induced by measles vi-
rus by changing the environment of the fusion pro-
tein and possibly its conformation [16].
Studies are currently in progress to investigate the
role of other lipids in the early stages of ASFV in-
fection. It will be interesting to know whether sphin-
golipids are involved in the process of activation of
ASFV uncoating.
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